HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HIGHTIDE-B

3.445

+0.0702.07%

Volume:574.00K

Turnover:1.84M

Market Cap:2.31B

PE:-6.75

High:3.450

Open:3.375

Low:3.100

Close:3.375

52wk High:4.720

52wk Low:1.800

Shares:670.00M

HK Float Shares:670.00M

Volume Ratio:1.41

T/O Rate:0.09%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.510

ROE:-58.85%

ROA:-25.15%

PB:6.44

PE(LYR):-6.75

PS:57.81

Loading ...

Overview Company News Filings

HighTide Therapeutics files directors list with Hong Kong Stock Exchange

HIGHTIDE-B Appoints Chen Mingyu as Independent Non-Executive Director

HighTide Therapeutics appoints Chen Mingyu as independent director, audit committee chair

HIGHTIDE-B聚焦CKM创新研发，2025年亏损大幅收窄至人民币2.321亿元

Bulletin Express

HighTide Therapeutics publishes 2025 annual report

HighTide Therapeutics Agrees to Lend HK$15 Million to CEO

MT Newswires Live

BRIEF-Hightide Therapeutics Enters Loan Agreement Up To HK$15 Million

HighTide Therapeutics Inc - Enters Loan Agreement up to HK$15 Mln on April 27, 2026

THOMSON REUTERS

HighTide Therapeutics Reports No Change in Share Capital for March 2026; Public Float Remains Compliant

Bulletin Express

HighTide narrows 2025 loss to RMB232.10 million as R&D spending halves; HTD1801 NDA accepted

Bulletin Express

HIGHTIDE-B Reports Annual Results: Shareholder Loss Narrows to 245 Million Yuan

Hightide Therapeutics FY2025 net loss narrows 39.2% to RMB232 million; other income drops 72.1% to RMB19 million

HighTide Therapeutics Inc - FY Loss Attributable RMB245 Mln

THOMSON REUTERS

HighTide Therapeutics-B (2511) Schedules 27 March 2026 Board Meeting to Approve FY 2025 Audited Results

Bulletin Express

HighTide Therapeutics Gets China Acceptance for Type 2 Diabetes Mellitus Drug

MT Newswires Live

BRIEF-HighTide Therapeutics Says NMPA China Accepts New Drug Application For HTD1801

HighTide-B (02511.HK) Secures NMPA Acceptance of First NDA for HTD1801 in Type 2 Diabetes

Bulletin Express

HIGHTIDE-B Receives NMPA Acceptance for New Drug Application of HTD1801

China NMPA accepts HighTide Therapeutics’ HTD1801 NDA for type 2 diabetes

HighTide Therapeutics Inc - Acceptance of New Drug Application for Htd1801 by China's Nmpa

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/02511/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02511","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02511\",,,,,undefined,":{"symbol":"02511","market":"HK","secType":"STK","nameCN":"HIGHTIDE-B","latestPrice":3.445,"timestamp":1787299200010,"preClose":3.375,"halted":0,"volume":574000,"delay":0,"changeRate":0.020740740740740695,"floatShares":670000000,"shares":670000000,"eps":-0.51,"marketStatus":"Market Closed","change":0.07,"latestTime":"08-21 16:00:00","open":3.375,"high":3.45,"low":3.1,"amount":1838462,"amplitude":0.103704,"askPrice":3.44,"askSize":10000,"bidPrice":3.135,"bidSize":8000,"shortable":0,"etf":0,"ttmEps":-0.405,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":7,"adr":0,"listingDate":1703174400000,"exchange":"SEHK","adjPreClose":3.375,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":1.4106660113396576,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02511\",,,,,undefined,":{"symbol":"02511","floatShares":670000000,"roa":"-25.15%","roe":"-58.85%","lyrEps":-0.51,"volumeRatio":1.4106660113396576,"shares":670000000,"dividePrice":0,"high":3.45,"amplitude":0.103704,"preClose":3.375,"low":3.1,"week52Low":1.8,"pbRate":"6.44","psRate":"57.81","week52High":4.72,"institutionHeld":0,"latestPrice":3.445,"committee":-0.111111,"eps":-0.51,"divideRate":0,"volume":574000,"delay":0,"ttmEps":-0.405,"open":3.375,"prevYearClose":2.95,"prevWeekClose":3.495,"prevMonthClose":2.6,"prevQuarterClose":2.68,"fiveDayClose":3.495,"twentyDayClose":2.65,"sixtyDayClose":3.32,"earningDate":1788105600000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02511\",params:#limit:5,,,undefined,":[{"date":"2026-08-31","symbol":"02511","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788139800000,"name":null,"time":"","dateTimestamp":1788105600000,"actualEps":null},{"date":"2026-03-27","symbol":"02511","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774575000000,"name":null,"time":"","dateTimestamp":1774540800000,"actualEps":null},{"date":"2025-03-28","symbol":"02511","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"Post-Mkt","dateTimestamp":1743091200000,"actualEps":null},{"market":"HK","date":"2024-08-28","symbol":"02511","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1724774400000,"reportTimeType":"post","actualEps":null},{"date":"2024-03-27","symbol":"02511","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711503000000,"name":null,"time":"","dateTimestamp":1711468800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02511\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02511\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02511\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02511","date":"2026-08-21","current":-8.506173,"percent":0.163859,"low":-9.21009,"twenty":-6.359873,"median":-4.259614,"eighty":-0.918869,"high":-0.503695,"avg":-3.962686,"sd":2.567691,"marketCap":1968216926},"quantilePoints":[{"date":"2023-12-22","current":-8.734639,"twenty":-8.492642,"median":-8.129647,"eighty":-8.127643,"marketCap":6372860869},{"date":"2023-12-29","current":-9.095359,"twenty":-8.98365,"median":-8.695581,"eighty":-8.129647,"marketCap":6671427857},{"date":"2024-01-05","current":-8.537988,"twenty":-8.784441,"median":-8.544038,"eighty":-8.248369,"marketCap":6218429669},{"date":"2024-01-12","current":-8.363907,"twenty":-8.685299,"median":-8.537988,"eighty":-8.346736,"marketCap":6094884709},{"date":"2024-01-19","current":-8.1349,"twenty":-8.659812,"median":-8.456167,"eighty":-8.207816,"marketCap":5919862682},{"date":"2024-01-26","current":-8.649584,"twenty":-8.650972,"median":-8.460912,"eighty":-8.207816,"marketCap":6269906736},{"date":"2024-02-02","current":-8.361984,"twenty":-8.650972,"median":-8.483943,"eighty":-8.264989,"marketCap":6053703055},{"date":"2024-02-09","current":-8.504973,"twenty":-8.597346,"median":-8.473421,"eighty":-8.275661,"marketCap":6187543429},{"date":"2024-02-16","current":-8.602173,"twenty":-8.63062,"median":-8.476958,"eighty":-8.294295,"marketCap":6259611322},{"date":"2024-02-23","current":-8.036159,"twenty":-8.595019,"median":-8.473421,"eighty":-8.208635,"marketCap":5816908548},{"date":"2024-03-01","current":-7.945863,"twenty":-8.576687,"median":-8.451284,"eighty":-8.127643,"marketCap":5755136068},{"date":"2024-03-08","current":-6.052653,"twenty":-8.560192,"median":-8.40877,"eighty":-7.978802,"marketCap":4385846091},{"date":"2024-03-15","current":-5.695388,"twenty":-8.551566,"median":-8.362945,"eighty":-7.867218,"marketCap":4123313050},{"date":"2024-03-22","current":-4.312815,"twenty":-8.548208,"median":-8.27805,"eighty":-6.066123,"marketCap":3119510248},{"date":"2024-03-28","current":-2.992001,"twenty":-8.543906,"median":-8.212744,"eighty":-5.745595,"marketCap":3042294647},{"date":"2024-04-05","current":-2.73463,"twenty":-8.539468,"median":-8.197001,"eighty":-5.576119,"marketCap":2779761607},{"date":"2024-04-12","current":-2.176341,"twenty":-8.534781,"median":-8.129647,"eighty":-4.493311,"marketCap":2213513872},{"date":"2024-04-19","current":-2.517594,"twenty":-8.523109,"median":-8.043912,"eighty":-4.309916,"marketCap":2558410219},{"date":"2024-04-26","current":-2.586635,"twenty":-8.508057,"median":-7.951497,"eighty":-2.864821,"marketCap":2625330406},{"date":"2024-05-03","current":-2.649329,"twenty":-8.498668,"median":-7.924262,"eighty":-2.751198,"marketCap":2687102886},{"date":"2024-05-10","current":-3.422806,"twenty":-8.484817,"median":-7.769212,"eighty":-2.737043,"marketCap":3479849715},{"date":"2024-05-17","current":-3.275714,"twenty":-8.477244,"median":-6.276091,"eighty":-2.747016,"marketCap":3325418515},{"date":"2024-05-24","current":-2.698739,"twenty":-8.474688,"median":-5.875073,"eighty":-2.745416,"marketCap":2733432247},{"date":"2024-05-31","current":-2.594452,"twenty":-8.468417,"median":-5.713034,"eighty":-2.710462,"marketCap":2630478113},{"date":"2024-06-07","current":-2.277412,"twenty":-8.457116,"median":-5.462224,"eighty":-2.655805,"marketCap":2306172592},{"date":"2024-06-14","current":-2.08615,"twenty":-8.451368,"median":-5.115854,"eighty":-2.588198,"marketCap":2110559738},{"date":"2024-06-21","current":-1.830485,"twenty":-8.444904,"median":-4.331734,"eighty":-2.536299,"marketCap":1848026698},{"date":"2024-06-28","current":-0.719236,"twenty":-8.417702,"median":-4.312815,"eighty":-2.477957,"marketCap":725826641},{"date":"2024-07-05","current":-0.596943,"twenty":-8.40877,"median":-4.051691,"eighty":-2.463651,"marketCap":602281681},{"date":"2024-07-12","current":-0.636823,"twenty":-8.366276,"median":-3.549353,"eighty":-2.277412,"marketCap":643463335},{"date":"2024-07-19","current":-0.560394,"twenty":-8.363907,"median":-3.496298,"eighty":-2.190964,"marketCap":566247734},{"date":"2024-07-26","current":-0.517715,"twenty":-8.361984,"median":-3.220684,"eighty":-2.08615,"marketCap":525066081},{"date":"2024-08-02","current":-0.75671,"twenty":-8.318662,"median":-2.992001,"eighty":-1.873562,"marketCap":767008295},{"date":"2024-08-09","current":-0.776926,"twenty":-8.27805,"median":-2.863181,"eighty":-0.894876,"marketCap":792746828},{"date":"2024-08-16","current":-0.766537,"twenty":-8.266106,"median":-2.770601,"eighty":-0.773016,"marketCap":782451415},{"date":"2024-08-23","current":-0.652832,"twenty":-8.212744,"median":-2.747107,"eighty":-0.75671,"marketCap":669201868},{"date":"2024-08-30","current":-1.100172,"twenty":-8.205896,"median":-2.728047,"eighty":-0.729206,"marketCap":725826641},{"date":"2024-09-06","current":-0.912468,"twenty":-8.188106,"median":-2.679629,"eighty":-0.740924,"marketCap":602281681},{"date":"2024-09-13","current":-0.656825,"twenty":-8.1349,"median":-2.649329,"eighty":-0.723174,"marketCap":432407361},{"date":"2024-09-20","current":-0.691774,"twenty":-8.130698,"median":-2.594452,"eighty":-0.718911,"marketCap":458145894},{"date":"2024-09-27","current":-0.788079,"twenty":-8.126975,"median":-2.574831,"eighty":-0.711909,"marketCap":525066081},{"date":"2024-10-04","current":-0.892575,"twenty":-8.081521,"median":-2.538273,"eighty":-0.714203,"marketCap":591986268},{"date":"2024-10-10","current":-0.882415,"twenty":-8.045462,"median":-2.524212,"eighty":-0.716377,"marketCap":581690854},{"date":"2024-10-18","current":-0.879542,"twenty":-8.029599,"median":-2.476753,"eighty":-0.71826,"marketCap":576543148},{"date":"2024-10-25","current":-0.879598,"twenty":-7.992455,"median":-2.46526,"eighty":-0.719628,"marketCap":576543148},{"date":"2024-11-01","current":-0.933943,"twenty":-7.949243,"median":-2.40723,"eighty":-0.720238,"marketCap":612577094},{"date":"2024-11-08","current":-0.972706,"twenty":-7.937223,"median":-2.272633,"eighty":-0.721432,"marketCap":633167921},{"date":"2024-11-15","current":-0.836682,"twenty":-7.912537,"median":-2.191611,"eighty":-0.725587,"marketCap":540509201},{"date":"2024-11-22","current":-0.837164,"twenty":-7.876462,"median":-2.165315,"eighty":-0.733893,"marketCap":540509201},{"date":"2024-11-29","current":-0.781798,"twenty":-7.785116,"median":-2.08615,"eighty":-0.746636,"marketCap":504475254},{"date":"2024-12-06","current":-0.799637,"twenty":-7.200158,"median":-1.899521,"eighty":-0.755806,"marketCap":514770668},{"date":"2024-12-13","current":-0.768352,"twenty":-6.314044,"median":-1.830485,"eighty":-0.757354,"marketCap":494179841},{"date":"2024-12-20","current":-0.917454,"twenty":-6.072858,"median":-1.096301,"eighty":-0.757354,"marketCap":586838561},{"date":"2024-12-27","current":-1.047032,"twenty":-6.052653,"median":-1.059897,"eighty":-0.758321,"marketCap":669201868},{"date":"2025-01-03","current":-0.89313,"twenty":-5.910589,"median":-1.030203,"eighty":-0.759127,"marketCap":571395441},{"date":"2025-01-10","current":-0.872296,"twenty":-5.819219,"median":-1.016579,"eighty":-0.765095,"marketCap":555952321},{"date":"2025-01-17","current":-0.928085,"twenty":-5.745595,"median":-0.982343,"eighty":-0.767989,"marketCap":591986268},{"date":"2025-01-24","current":-0.890226,"twenty":-5.702446,"median":-0.971737,"eighty":-0.768352,"marketCap":571395441},{"date":"2025-01-28","current":-0.909941,"twenty":-5.677229,"median":-0.965955,"eighty":-0.76868,"marketCap":586838561},{"date":"2025-02-07","current":-0.962836,"twenty":-5.576119,"median":-0.960006,"eighty":-0.770428,"marketCap":617724801},{"date":"2025-02-14","current":-0.916884,"twenty":-5.437951,"median":-0.957687,"eighty":-0.772342,"marketCap":586838561},{"date":"2025-02-21","current":-1.079861,"twenty":-5.295856,"median":-0.96114,"eighty":-0.773201,"marketCap":694940401},{"date":"2025-02-28","current":-0.922924,"twenty":-4.99937,"median":-0.960573,"eighty":-0.77414,"marketCap":591986268},{"date":"2025-03-07","current":-0.807326,"twenty":-4.493311,"median":-0.957265,"eighty":-0.775085,"marketCap":519918374},{"date":"2025-03-14","current":-0.966841,"twenty":-4.332382,"median":-0.951297,"eighty":-0.775904,"marketCap":622872508},{"date":"2025-03-21","current":-1.151073,"twenty":-4.329727,"median":-0.958109,"eighty":-0.776927,"marketCap":741269761},{"date":"2025-03-28","current":-1.305593,"twenty":-4.323383,"median":-0.961988,"eighty":-0.77695,"marketCap":839076188},{"date":"2025-04-03","current":-1.964669,"twenty":-4.312815,"median":-0.968609,"eighty":-0.77703,"marketCap":803042242},{"date":"2025-04-11","current":-1.804502,"twenty":-4.298321,"median":-0.972706,"eighty":-0.779537,"marketCap":730974348},{"date":"2025-04-17","current":-2.094006,"twenty":-4.101017,"median":-0.982343,"eighty":-0.781346,"marketCap":849371602},{"date":"2025-04-25","current":-2.153289,"twenty":-3.838494,"median":-0.984395,"eighty":-0.781962,"marketCap":875110135},{"date":"2025-05-02","current":-2.275118,"twenty":-3.638788,"median":-0.998444,"eighty":-0.782191,"marketCap":926587202},{"date":"2025-05-09","current":-3.363784,"twenty":-3.551198,"median":-1.021661,"eighty":-0.782445,"marketCap":1379585390},{"date":"2025-05-16","current":-3.99636,"twenty":-3.977419,"median":-1.026921,"eighty":-0.783805,"marketCap":1652413844},{"date":"2025-05-23","current":-3.475525,"twenty":-3.891419,"median":-1.043315,"eighty":-0.788891,"marketCap":1441357870},{"date":"2025-05-30","current":-2.595234,"twenty":-3.819658,"median":-1.05978,"eighty":-0.79364,"marketCap":1081018402},{"date":"2025-06-06","current":-3.217297,"twenty":-3.690833,"median":-1.079861,"eighty":-0.799918,"marketCap":1343551443},{"date":"2025-06-13","current":-3.979986,"twenty":-3.819658,"median":-1.125622,"eighty":-0.801093,"marketCap":1662709257},{"date":"2025-06-20","current":-3.555688,"twenty":-3.891829,"median":-1.260849,"eighty":-0.802505,"marketCap":1482539523},{"date":"2025-06-27","current":-3.398018,"twenty":-3.858555,"median":-1.338636,"eighty":-0.807993,"marketCap":1420767043},{"date":"2025-07-04","current":-3.348614,"twenty":-3.850482,"median":-1.395853,"eighty":-0.810663,"marketCap":1400176216},{"date":"2025-07-11","current":-4.33787,"twenty":-3.901653,"median":-1.565723,"eighty":-0.818449,"marketCap":1811992751},{"date":"2025-07-18","current":-4.941417,"twenty":-4.032449,"median":-1.709388,"eighty":-0.827717,"marketCap":2062485661},{"date":"2025-07-25","current":-4.84168,"twenty":-4.072278,"median":-1.830485,"eighty":-0.829191,"marketCap":2028206121},{"date":"2025-08-01","current":-4.226787,"twenty":-4.272195,"median":-1.888937,"eighty":-0.829739,"marketCap":1759683057},{"date":"2025-08-08","current":-4.394198,"twenty":-4.326025,"median":-1.964669,"eighty":-0.830438,"marketCap":1833955394},{"date":"2025-08-15","current":-4.551598,"twenty":-4.330653,"median":-2.021536,"eighty":-0.833182,"marketCap":1896801217},{"date":"2025-08-22","current":-4.428389,"twenty":-4.337848,"median":-2.077326,"eighty":-0.833612,"marketCap":1839668650},{"date":"2025-08-29","current":-6.120211,"twenty":-4.380509,"median":-2.09259,"eighty":-0.836682,"marketCap":1948220527},{"date":"2025-09-05","current":-6.359835,"twenty":-4.480886,"median":-2.122167,"eighty":-0.837164,"marketCap":2022492864},{"date":"2025-09-12","current":-7.854809,"twenty":-4.551598,"median":-2.149237,"eighty":-0.837164,"marketCap":2502406425},{"date":"2025-09-19","current":-7.860387,"twenty":-4.786316,"median":-2.153472,"eighty":-0.838292,"marketCap":2502406425},{"date":"2025-09-26","current":-7.017182,"twenty":-4.941417,"median":-2.183652,"eighty":-0.84547,"marketCap":2228170105},{"date":"2025-10-03","current":-7.036374,"twenty":-5.00868,"median":-2.202955,"eighty":-0.847167,"marketCap":2239596618},{"date":"2025-10-10","current":-6.399502,"twenty":-5.389404,"median":-2.271485,"eighty":-0.847613,"marketCap":2033919378},{"date":"2025-10-17","current":-6.134636,"twenty":-5.76051,"median":-2.316794,"eighty":-0.84775,"marketCap":1948220527},{"date":"2025-10-24","current":-6.635946,"twenty":-5.949231,"median":-2.385869,"eighty":-0.85134,"marketCap":2108191714},{"date":"2025-10-31","current":-6.715847,"twenty":-6.05096,"median":-2.429559,"eighty":-0.85508,"marketCap":2136757998},{"date":"2025-11-07","current":-5.803675,"twenty":-6.064964,"median":-2.466868,"eighty":-0.858385,"marketCap":1845381907},{"date":"2025-11-14","current":-5.357261,"twenty":-6.05096,"median":-2.479762,"eighty":-0.861761,"marketCap":1708263747},{"date":"2025-11-21","current":-5.162577,"twenty":-6.038234,"median":-2.53083,"eighty":-0.864616,"marketCap":1645417923},{"date":"2025-11-28","current":-5.001007,"twenty":-6.009542,"median":-2.552457,"eighty":-0.867916,"marketCap":1599711870},{"date":"2025-12-05","current":-5.349025,"twenty":-5.978814,"median":-2.586635,"eighty":-0.871961,"marketCap":1713977004},{"date":"2025-12-12","current":-4.983206,"twenty":-5.953787,"median":-2.601318,"eighty":-0.872449,"marketCap":1599711870},{"date":"2025-12-19","current":-4.651894,"twenty":-5.93877,"median":-2.665519,"eighty":-0.874932,"marketCap":1496873250},{"date":"2025-12-24","current":-5.398557,"twenty":-5.936744,"median":-2.679629,"eighty":-0.878314,"marketCap":1742543287},{"date":"2026-01-02","current":-5.342132,"twenty":-5.93091,"median":-2.713393,"eighty":-0.879024,"marketCap":1731116774},{"date":"2026-01-09","current":-4.766078,"twenty":-5.885949,"median":-2.738651,"eighty":-0.879423,"marketCap":1548292560},{"date":"2026-01-16","current":-4.978531,"twenty":-5.819219,"median":-2.765082,"eighty":-0.879529,"marketCap":1622564897},{"date":"2026-01-23","current":-4.878031,"twenty":-5.803991,"median":-2.784006,"eighty":-0.879587,"marketCap":1588285357},{"date":"2026-01-30","current":-4.681162,"twenty":-5.745279,"median":-2.863181,"eighty":-0.879613,"marketCap":1531152790},{"date":"2026-02-06","current":-4.617051,"twenty":-5.717934,"median":-2.968411,"eighty":-0.881855,"marketCap":1514013020},{"date":"2026-02-13","current":-4.504066,"twenty":-5.69926,"median":-3.043338,"eighty":-0.884318,"marketCap":1485446736},{"date":"2026-02-20","current":-4.579955,"twenty":-5.677229,"median":-3.125093,"eighty":-0.885389,"marketCap":1508299763},{"date":"2026-02-27","current":-3.963988,"twenty":-5.577917,"median":-3.204815,"eighty":-0.887935,"marketCap":1319762293},{"date":"2026-03-06","current":-4.1519,"twenty":-5.469414,"median":-3.251491,"eighty":-0.88893,"marketCap":1371181603},{"date":"2026-03-13","current":-5.217742,"twenty":-5.459149,"median":-3.275714,"eighty":-0.890696,"marketCap":1731116774},{"date":"2026-03-20","current":-5.289432,"twenty":-5.577917,"median":-3.30169,"eighty":-0.892686,"marketCap":1748256544},{"date":"2026-03-27","current":-5.060306,"twenty":-5.469414,"median":-3.335097,"eighty":-0.893479,"marketCap":1668270950},{"date":"2026-04-02","current":-6.682697,"twenty":-5.695388,"median":-3.354467,"eighty":-0.894876,"marketCap":1862521677},{"date":"2026-04-10","current":-7.282499,"twenty":-5.759878,"median":-3.364724,"eighty":-0.895625,"marketCap":2045345891},{"date":"2026-04-17","current":-7.808117,"twenty":-5.893202,"median":-3.390855,"eighty":-0.89632,"marketCap":2193890565},{"date":"2026-04-24","current":-7.380692,"twenty":-5.949231,"median":-3.402792,"eighty":-0.896628,"marketCap":2073912174},{"date":"2026-04-30","current":-7.802804,"twenty":-6.009542,"median":-3.409801,"eighty":-0.898342,"marketCap":2193890565},{"date":"2026-05-08","current":-8.386383,"twenty":-6.077222,"median":-3.475525,"eighty":-0.900995,"marketCap":2365288265},{"date":"2026-05-15","current":-7.697657,"twenty":-6.124329,"median":-3.511178,"eighty":-0.901676,"marketCap":2176750795},{"date":"2026-05-22","current":-6.925535,"twenty":-6.207177,"median":-3.546278,"eighty":-0.903438,"marketCap":1953933784},{"date":"2026-05-29","current":-6.154879,"twenty":-6.347522,"median":-3.555688,"eighty":-0.906191,"marketCap":1742543287},{"date":"2026-06-05","current":-6.025055,"twenty":-6.290382,"median":-3.643852,"eighty":-0.909379,"marketCap":1708263747},{"date":"2026-06-12","current":-5.766997,"twenty":-6.255585,"median":-3.719411,"eighty":-0.910432,"marketCap":1633991410},{"date":"2026-06-18","current":-5.976186,"twenty":-6.258832,"median":-3.850482,"eighty":-0.912396,"marketCap":1696837233},{"date":"2026-06-26","current":-5.437776,"twenty":-6.242599,"median":-3.900648,"eighty":-0.912468,"marketCap":1536866046},{"date":"2026-07-03","current":-5.534709,"twenty":-6.240058,"median":-3.955132,"eighty":-0.912643,"marketCap":1565432330},{"date":"2026-07-10","current":-5.319041,"twenty":-6.236625,"median":-3.979986,"eighty":-0.914441,"marketCap":1502586506},{"date":"2026-07-17","current":-5.239721,"twenty":-6.227183,"median":-4.04207,"eighty":-0.915359,"marketCap":1485446736},{"date":"2026-07-24","current":-5.339284,"twenty":-6.220001,"median":-4.070499,"eighty":-0.916603,"marketCap":1514013020},{"date":"2026-07-31","current":-5.228611,"twenty":-6.180428,"median":-4.127576,"eighty":-0.916933,"marketCap":1485446736},{"date":"2026-08-07","current":-6.824164,"twenty":-6.226495,"median":-4.153193,"eighty":-0.917258,"marketCap":1942507271},{"date":"2026-08-14","current":-7.005969,"twenty":-6.249092,"median":-4.222567,"eighty":-0.918172,"marketCap":1996783209},{"date":"2026-08-21","current":-6.890513,"twenty":-6.359873,"median":-4.259614,"eighty":-0.918869,"marketCap":1968216926}],"updateTime":1787469638873},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02511\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2632517931","title":"HighTide Therapeutics files directors list with Hong Kong Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2632517931","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632517931?lang=en_us&edition=fundamental","pubTime":"2026-05-04 17:12","pubTimestamp":1777885929,"startTime":"0","endTime":"0","summary":"Hightide Therapeutics filed an updated list of directors with Hong Kong Stock Exchange on May 4, 2026.Board comprised of two executive directors, including Chairwoman and CEO Liu Liping, three non-executive directors, three independent non-executive directors.Committee roles set out across audit, remuneration, nomination committees; Chen Mingyu chairs audit committee, Li Jin chairs remuneration committee, Liu Liping chairs nomination committee.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hightide Therapeutics Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 04, 2026, and is solely responsible for the information contained t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDL4J1vSp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02511","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166967425","title":"HIGHTIDE-B Appoints Chen Mingyu as Independent Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1166967425","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166967425?lang=en_us&edition=fundamental","pubTime":"2026-05-04 17:10","pubTimestamp":1777885822,"startTime":"0","endTime":"0","summary":"HIGHTIDE-B (02511) has announced the appointment of Mr. Chen Mingyu as an independent non-executive director, chairman of the company’s audit committee, and a member of the remuneration committee. The appointments will take effect from May 4, 2026.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632993159","title":"HighTide Therapeutics appoints Chen Mingyu as independent director, audit committee chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2632993159","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632993159?lang=en_us&edition=fundamental","pubTime":"2026-05-04 17:06","pubTimestamp":1777885576,"startTime":"0","endTime":"0","summary":"Hightide Therapeutics named Chen Mingyu independent non-executive director effective May 4, 2026.Chen took over as audit committee chair, joining remuneration committee; he is managing partner at D&E  Business Consulting, former partner at Deloitte, Ernst & Young, KPMG, currently audit committee chair at Yadea Group Holdings.Tan Bo resigned as independent non-executive director effective May 4, 2026, stepping down as audit committee chair, exiting remuneration committee.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hightide Therapeutics Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 04, 2026, and is solely responsible for ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDL9r5QGB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1039395188.USD","BK1161","BK1589","LU1115378108.SGD","LU2238339852.HKD","01585","BK1111","LU0823437842.USD","LU2506952253.HKD","BK1509","BK1502","02511","LU1939255532.USD","LU2298064838.USD","LU0640798160.USD","IE00B29SXG58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104359732","title":"HIGHTIDE-B聚焦CKM创新研发，2025年亏损大幅收窄至人民币2.321亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1104359732","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104359732?lang=en_us&edition=fundamental","pubTime":"2026-04-29 19:46","pubTimestamp":1777463172,"startTime":"0","endTime":"0","summary":"HIGHTIDE-B是一家在香港联合交易所有限公司（「联交所」）上市的创新型医药企业（股票代码：02511），注册于开曼群岛，总部位于中国深圳，并在香港及海外多地设有业务及研发机构。公司董事会下设审核委员会、薪酬委员会及提名委员会，董事会成员包括执行董事、非执行董事及独立非执行董事，形成了多元且稳健的公司治理架构。...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"HIGHTIDE-B聚焦CKM创新研发，2025年亏损大幅收窄至人民币2.321亿元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631151324","title":"HighTide Therapeutics publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2631151324","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631151324?lang=en_us&edition=fundamental","pubTime":"2026-04-29 19:31","pubTimestamp":1777462263,"startTime":"0","endTime":"0","summary":"HighTide Therapeutics published its 2025 annual report, highlighting late-stage progress for lead candidate HTD1801 across cardiovascular-kidney-metabolic diseases.HTD1801 completed three pivotal Phase III trials in type 2 diabetes in Mainland China in 2025, supporting an NDA accepted by China NMPA in March 2026.Phase III HARMONY study showed HTD1801 met primary endpoint versus dapagliflozin at Week 24, with stronger trends on selected cardiometabolic markers.Global Phase IIb MASH trial for HTD1801 completed, prompting review of next development steps based on overall dataset and regulatory feedback.Company shifted focus toward commercialization planning, including pursuit of domestic partners to support China launch execution for HTD1801.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be int","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL8fwZ3M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630532547","title":"HighTide Therapeutics Agrees to Lend HK$15 Million to CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2630532547","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630532547?lang=en_us&edition=fundamental","pubTime":"2026-04-28 12:17","pubTimestamp":1777349869,"startTime":"0","endTime":"0","summary":"HighTide Therapeutics  agreed to lend up to HK$15 million to its CEO Liu Liping, it said in a Monday Hong Kong bourse filing.The pharmaceutical company's shares fell 1% in early afternoon trade Tuesday.Borrowings under the facility are payable a year from drawdown and will accrue interest at 3.50% per annum.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","BK4139","BK4007","BK1161","02511","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630138313","title":"BRIEF-Hightide Therapeutics Enters Loan Agreement Up To HK$15 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2630138313","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630138313?lang=en_us&edition=fundamental","pubTime":"2026-04-27 23:28","pubTimestamp":1777303710,"startTime":"0","endTime":"0","summary":"BRIEF-Hightide Therapeutics Enters Loan Agreement Up To HK$15 MillionApril 27 (Reuters) - HighTide Therapeutics Inc 2511.HK:ENTERS LOAN AGREEMENT UP TO HK$15 MILLION ON APRIL 27, 2026Further company coverage: 2511.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nFWN41A0R9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02511","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630139096","title":"HighTide Therapeutics Inc - Enters Loan Agreement up to HK$15 Mln on April 27, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2630139096","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630139096?lang=en_us&edition=fundamental","pubTime":"2026-04-27 22:24","pubTimestamp":1777299888,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nFWN41A0R9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195680748","title":"HighTide Therapeutics Reports No Change in Share Capital for March 2026; Public Float Remains Compliant","url":"https://stock-news.laohu8.com/highlight/detail?id=1195680748","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195680748?lang=en_us&edition=fundamental","pubTime":"2026-04-01 16:55","pubTimestamp":1775033711,"startTime":"0","endTime":"0","summary":"HighTide Therapeutics, Inc. (HIGHTIDE-B) submitted its Monthly Return for the period ended 31 March 2026, confirming that both authorised and issued share capital were unchanged during the month....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170953825","title":"HighTide narrows 2025 loss to RMB232.10 million as R&D spending halves; HTD1801 NDA accepted","url":"https://stock-news.laohu8.com/highlight/detail?id=1170953825","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170953825?lang=en_us&edition=fundamental","pubTime":"2026-03-27 18:26","pubTimestamp":1774607198,"startTime":"0","endTime":"0","summary":"HighTide Therapeutics (HIGHTIDE-B, 02511) reported a RMB232.10 million net loss for 2025, a 39.2% improvement from 2024’s RMB381.79 million, mainly due to sharply lower R&D costs. • Income statement...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117063893","title":"HIGHTIDE-B Reports Annual Results: Shareholder Loss Narrows to 245 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1117063893","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117063893?lang=en_us&edition=fundamental","pubTime":"2026-03-27 18:24","pubTimestamp":1774607068,"startTime":"0","endTime":"0","summary":"HIGHTIDE-B (02511) announced its annual results for the period ending December 31, 2025. The group recorded other income of 19.007 million yuan, a decrease of 72.04% compared to the previous year....","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622364840","title":"Hightide Therapeutics FY2025 net loss narrows 39.2% to RMB232 million; other income drops 72.1% to RMB19 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622364840","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622364840?lang=en_us&edition=fundamental","pubTime":"2026-03-27 18:18","pubTimestamp":1774606709,"startTime":"0","endTime":"0","summary":"HighTide Therapeutics published an annual results announcement reporting a net loss of RMB232.1 million and a basic and diluted loss per share of RMB0.51.Other income fell 72.1% to RMB19.01 million, primarily due to lower government grants and reduced investment income from financial assets at FVTPL.Other losses-net widened to RMB24.95 million from RMB3.2 million, driven mainly by higher fair value losses on financial assets at FVTPL.Research and development costs decreased 54.7% to RMB164.47 million, mainly reflecting lower third-party contracting expenses.Liquidity updates included current assets of RMB532.19 million and a current ratio of 5.4, while gearing rose to 30.2% and outstanding interest-bearing bank borrowings totaled RMB110.0 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should no","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL5BM7HJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02511","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622840350","title":"HighTide Therapeutics Inc - FY  Loss Attributable RMB245 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2622840350","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622840350?lang=en_us&edition=fundamental","pubTime":"2026-03-27 18:18","pubTimestamp":1774606701,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nFWN40E1AS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02511","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152794578","title":"HighTide Therapeutics-B (2511) Schedules 27 March 2026 Board Meeting to Approve FY 2025 Audited Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1152794578","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152794578?lang=en_us&edition=fundamental","pubTime":"2026-03-13 18:04","pubTimestamp":1773396254,"startTime":"0","endTime":"0","summary":"HighTide Therapeutics, Inc. (HIGHTIDE-B, 2511) has announced that its board of directors will convene on Friday, 27 March 2026. The primary agenda is to review and approve the audited consolidated...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618932124","title":"HighTide Therapeutics Gets China Acceptance for Type 2 Diabetes Mellitus Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2618932124","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618932124?lang=en_us&edition=fundamental","pubTime":"2026-03-10 19:28","pubTimestamp":1773142132,"startTime":"0","endTime":"0","summary":"HighTide Therapeutics (HKG:2511) received acceptance for its new drug application for HTD1801 from China's National Medical Products Administration, according to a Tuesday Hong Kong bourse filing.The acceptance is for the drug as treatment for type 2 diabetes mellitus.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","LENZ","BK1161","BK4007","BK4139","02511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618093978","title":"BRIEF-HighTide Therapeutics Says NMPA China Accepts New Drug Application For HTD1801","url":"https://stock-news.laohu8.com/highlight/detail?id=2618093978","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618093978?lang=en_us&edition=fundamental","pubTime":"2026-03-10 18:28","pubTimestamp":1773138538,"startTime":"0","endTime":"0","summary":"BRIEF-HighTide Therapeutics Says NMPA China Accepts New Drug Application For HTD1801March 10 (Reuters) - HighTide Therapeutics Inc 2511.HK:ACCEPTANCE OF NEW DRUG APPLICATION FOR HTD1801 BY CHINA'S NMPAFurther company coverage: 2511.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nFWN3ZY074:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116616793","title":"HighTide-B (02511.HK) Secures NMPA Acceptance of First NDA for HTD1801 in Type 2 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=1116616793","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116616793?lang=en_us&edition=fundamental","pubTime":"2026-03-10 18:02","pubTimestamp":1773136964,"startTime":"0","endTime":"0","summary":"HighTide Therapeutics, Inc. (HighTide-B, 02511.HK) announced that China’s National Medical Products Administration has formally accepted the company’s New Drug Application for HTD1801, targeting the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181902635","title":"HIGHTIDE-B Receives NMPA Acceptance for New Drug Application of HTD1801","url":"https://stock-news.laohu8.com/highlight/detail?id=1181902635","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181902635?lang=en_us&edition=fundamental","pubTime":"2026-03-10 17:28","pubTimestamp":1773134896,"startTime":"0","endTime":"0","summary":"HIGHTIDE-B (02511) announced that China's National Medical Products Administration (NMPA) has accepted the New Drug Application (NDA) for HTD1801 for the treatment of Type 2 Diabetes (T2DM). This...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618765933","title":"China NMPA accepts HighTide Therapeutics’ HTD1801 NDA for type 2 diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2618765933","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618765933?lang=en_us&edition=fundamental","pubTime":"2026-03-10 17:21","pubTimestamp":1773134516,"startTime":"0","endTime":"0","summary":"HighTide Therapeutics said China’s National Medical Products Administration accepted its new drug application for HTD1801 to treat type 2 diabetes. The company said HTD1801 completed three Phase III trials in type 2 diabetes that met their primary endpoints.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hightide Therapeutics Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 10, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nNDLdrYvh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618933754","title":"HighTide Therapeutics Inc - Acceptance of New Drug Application for Htd1801 by China's Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2618933754","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618933754?lang=en_us&edition=fundamental","pubTime":"2026-03-10 17:21","pubTimestamp":1773134503,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nFWN3ZY074:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02511"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":41,"code":"91000000","status":"200"}]}}